CRP (mg/L) | <5 | 5 - 10 | 11 - 35 | >35 | >10 | ||
No. of Patients | 34 | 23 | 46 | 15 | 61 | ||
Killip | I | 30 (88.2) | 17 (74) | 26 (56.5) | 2 (13.3)* | 28 (45.9) | |
II | 4 (11.8) | 3 (13) | 10 (21.7) | 6 (40)* | 16 (26.2) | ||
III | 0* | 3 (13) | 7 (15.3) | 3 (20) | 10 (16.4) | ||
IV | 0* | 0* | 3 (6.5) | 4 (26.7) | 7 (11.5) | ||
LVEF | >40% | 30 (88.2) | 15 (65.2) | 18 (39.1)* | 3 (20)* | 21(34.4) | |
30% - 39% | 4 (11.8) | 4 (17.4) | 18 (39.1)* | 2 (13.3) | 20 (32.8) | ||
<30% | 0 | 4 (17.4) | 10 (21.8) | 10 (66.7)* | 20 (32.8)* | ||
No. of Patients with CA | 28 | 18 | 32 | 7 | 39 | ||
1VD | 15 (53.6) | 7 (38.9) | 8 (25) | 1 (14.3)* | 9 (23.1) | ||
2VD | 10 (35.7) | 7 (38.9) | 7 (21.9) | 0 | 7 (17.9) | ||
3VD | 3 (10.7) | 4 (22.2) | 17 (53.1)* | 6 (85.7)* | 23 (59)* | ||